Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
57.26 USD | +2.54% |
|
+7.35% | +108.22% |
Jul. 08 | Merus Begins Phase 2 Trial of Colorectal Cancer Drug Candidate | MT |
Jul. 08 | Merus Initiates Mid-stage Study of Colorectal Cancer Combination Therapy | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+108.22% | 3.79B | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- MRUS Stock
- News Merus N.V.
- Needham Raises Price Target on Merus to $65 From $42, Keeps Buy Rating